Loading...
XCNQ
LVT
, Last price  
CAD
Name

Levitee Labs Inc

Chart & performance

D1W1MN
XCNQ:LVT chart
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
—
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
001,721,45600
Net income
0
-310,306-457,953-11,402,68200
CFO
0
-87,644-159,402-4,630,06300

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in Vancouver, Canada, Levitee Labs Inc., established in 2019, functions as a comprehensive wellness enterprise. The company is dedicated to delivering evidence-backed alternative medical treatments and pioneering psychedelic therapies, operating through its Medical Services and Selling Products divisions. Within its medical operations, Levitee Labs provides care and prescriptions for a range of conditions, including substance use disorders, various chronic pain conditions such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, in addition to Hepatitis-C and diverse mental health issues. This segment encompasses the management of five Levitee Clinics and three Levitee Pharmacies situated in Alberta. Furthermore, the company facilitates electronic prescriptions for addiction treatment via its BlockMD platform and distributes a selection of wholesale supplements and superfoods under the Earth Circle Organics brand. The organization adopted its current name, Levitee Labs Inc., on November 30, 2020, having previously been known as Fibonacci Capital Corp.
IPO date
Jul 21, 2021
Employees
Domiciled in
CA
Incorporated in
CA
Headquarters & legal address
215-800 W Pender Street
Vancouver, BC V6C 1J8
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑092022‑092021‑092020‑092019‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT